BD Broncus inhales $38M to treat lung disease, eyes IPO December 5th, 2008 Broncus Technologies, developer of devices to treat emphysema and other lung ailments, may make a second run at going public after bringing in $38 million in seventh-round funding to break even, reports VentureWire.